Plan B CARE Program Tries To Take Rx Risk Management Over-The-Counter
Executive Summary
The Convenient Access, Responsible Education (CARE) program for Plan B underscores the complexities of translating risk management tools for prescription products to the over-the-counter setting
You may also be interested in...
FDA Plans Behind-The-Counter Meeting, Mulls “Transitional” Status
FDA will discuss the idea of behind-the-counter drug sales as a possible transitional stage between Rx and OTC status when it holds a forum on the topic with stakeholders
FDA Plans Behind-The-Counter Meeting, Mulls “Transitional” Status
FDA will discuss the idea of behind-the-counter drug sales as a possible transitional stage between Rx and OTC status when it holds a forum on the topic with stakeholders
Risk Management Could Bolster FDA Behind-The-Counter Switches – Gottlieb
FDA's authority to require behind-the-counter sale and other restrictions for some nonprescription switches is strengthened by risk management provisions of "FDA Revitalization" bills pending in Congress, according to former FDA Deputy Commissioner Scott Gottlieb